These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29738666)

  • 1. Co-Stabilization of Amorphous Pharmaceuticals-The Case of Nifedipine and Nimodipine.
    Knapik-Kowalczuk J; Tu W; Chmiel K; Rams-Baron M; Paluch M
    Mol Pharm; 2018 Jun; 15(6):2455-2465. PubMed ID: 29738666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Storage Time Improve the Physical Stability of Amorphous Pharmaceuticals with Tautomerization Ability Exposed to Compression? The Case of a Chloramphenicol Drug.
    Knapik-Kowalczuk J; Wojnarowska Z; Chmiel K; Rams-Baron M; Tajber L; Paluch M
    Mol Pharm; 2018 May; 15(5):1928-1940. PubMed ID: 29584436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical stability of the amorphous anticholesterol agent (ezetimibe): the role of molecular mobility.
    Knapik J; Wojnarowska Z; Grzybowska K; Hawelek L; Sawicki W; Wlodarski K; Markowski J; Paluch M
    Mol Pharm; 2014 Nov; 11(11):4280-90. PubMed ID: 25310722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frozen in Time: Kinetically Stabilized Amorphous Solid Dispersions of Nifedipine Stable after a Quarter Century of Storage.
    Theil F; Anantharaman S; Kyeremateng SO; van Lishaut H; Dreis-Kühne SH; Rosenberg J; Mägerlein M; Woehrle GH
    Mol Pharm; 2017 Jan; 14(1):183-192. PubMed ID: 28043131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Excipient Interactions: Effect on Molecular Mobility and Physical Stability of Ketoconazole-Organic Acid Coamorphous Systems.
    Fung MH; DeVault M; Kuwata KT; Suryanarayanan R
    Mol Pharm; 2018 Mar; 15(3):1052-1061. PubMed ID: 29309158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isothermal Crystallization and Time-Temperature Transformation of Amorphous Nifedipine: A Case of Polymorphism Formation and Conversion.
    Cheng S; McKenna GB
    Mol Pharm; 2021 Jul; 18(7):2786-2802. PubMed ID: 34105978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying the Impact of Modified Saccharides on the Molecular Dynamics and Crystallization Tendencies of Model API Nifedipine.
    Kaminska E; Tarnacka M; Wlodarczyk P; Jurkiewicz K; Kolodziejczyk K; Dulski M; Haznar-Garbacz D; Hawelek L; Kaminski K; Wlodarczyk A; Paluch M
    Mol Pharm; 2015 Aug; 12(8):3007-19. PubMed ID: 26101945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxation Dynamics vs Crystallization Kinetics in the Amorphous State: The Case of Stiripentol.
    Ruiz GN; Romanini M; Barrio M; Tamarit JL; Pardo LC; Macovez R
    Mol Pharm; 2017 Nov; 14(11):3636-3643. PubMed ID: 28915351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photostability of crystalline versus amorphous nifedipine and nimodipine.
    Grooff D; Francis F; De Villiers MM; Ferg E
    J Pharm Sci; 2013 Jun; 102(6):1883-1894. PubMed ID: 23592327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.
    Valenti S; Barrio M; Negrier P; Romanini M; Macovez R; Tamarit JL
    Mol Pharm; 2021 Apr; 18(4):1819-1832. PubMed ID: 33689364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Physical Stability of Supercooled Etoricoxib after Compression.
    Rams-Baron M; Pacułt J; Jędrzejowska A; Knapik-Kowalczuk J; Paluch M
    Mol Pharm; 2018 Sep; 15(9):3969-3978. PubMed ID: 30052449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Dynamics and Physical Stability of Coamorphous Ezetimib and Indapamide Mixtures.
    Knapik J; Wojnarowska Z; Grzybowska K; Jurkiewicz K; Tajber L; Paluch M
    Mol Pharm; 2015 Oct; 12(10):3610-9. PubMed ID: 26301858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
    Aucamp M; Milne M; Liebenberg W
    AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Dynamics, Recrystallization Behavior, and Water Solubility of the Amorphous Anticancer Agent Bicalutamide and Its Polyvinylpyrrolidone Mixtures.
    Szczurek J; Rams-Baron M; Knapik-Kowalczuk J; Antosik A; Szafraniec J; Jamróz W; Dulski M; Jachowicz R; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1071-1081. PubMed ID: 28231007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin as a Promising Crystallization Inhibitor of Amorphous Probucol: Dielectric Studies at Ambient and Elevated Pressure.
    Knapik-Kowalczuk J; Wojnarowska Z; Rams-Baron M; Jurkiewicz K; Cielecka-Piontek J; Ngai KL; Paluch M
    Mol Pharm; 2017 Aug; 14(8):2670-2680. PubMed ID: 28692796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights into the crystallization of coamorphous drug systems.
    Heng W; Song Y; Luo M; Hu E; Wei Y; Gao Y; Pang Z; Zhang J; Qian S
    J Control Release; 2023 Feb; 354():489-502. PubMed ID: 36646287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of molecular mobility on the physical stability of amorphous pharmaceuticals in the supercooled and glassy States.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2014 Sep; 11(9):3048-55. PubMed ID: 25105216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in the experimental investigations of relaxations in pharmaceuticals by dielectric techniques at ambient and elevated pressure.
    Grzybowska K; Capaccioli S; Paluch M
    Adv Drug Deliv Rev; 2016 May; 100():158-82. PubMed ID: 26705851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxation dynamics and crystallization study of sildenafil in the liquid and glassy states.
    Kolodziejczyk K; Paluch M; Grzybowska K; Grzybowski A; Wojnarowska Z; Hawelek L; Ziolo JD
    Mol Pharm; 2013 Jun; 10(6):2270-82. PubMed ID: 23594226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and Hypercholesterolemia.
    Martínez-Jiménez C; Cruz-Angeles J; Videa M; Martínez LM
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30154310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.